Avant Diagnostics Competitors and Similar CompaniesClear all
Avant Diagnostics's competitors and similar companies include LC Sciences, Biocept, Genetic Technologies and Veracyte IO.
 Avant Diagnostics Avant Diagnostics is a medical diagnostic technology company that specializes in large panel biomarker screening. |  Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. |  Genetic Technologies Genetic Technologies is a molecular diagnostics company that develops and commercializes genetic risk assessment technology. |  Veracyte IO Veracyte IO (also known as HalioDx) is an immuno-oncology diagnostic company providing oncologists with immune-based diagnostic products and services. | ||
Founding Date | Founding Date 2012 | Founding Date 2004 | Founding Date 1993 | Founding Date 1989 | Founding Date 2014 |
Type | Type Private | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Washington, US HQ | Locations Houston, US HQ | Locations San Diego, US HQ | Locations Fitzroy, AU HQ Charlotte, US | Locations Marseille, FR HQ Richmond, US |
Employees | Employees 3 | Employees 20 | Employees 878% decrease | Employees 55 | Employees 741% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.7 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $25.9m (FY, 2022) | Revenue (est.) $7.7m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $28.4m (FY, 2022) | Cost of goods $3.8m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ($2.5m) (FY, 2022) | Gross profit $5.9m (FY, 2024) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income ($32.1m) (FY, 2022) | Net income ($12m) (FY, 2024) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 1.3m | Total funding raised N/A | Total funding raised $ 15.9m | Total funding raised N/A | Total funding raised $ 31.6m |
For sources of this data, please see the company profile
View Company Profiles
Biocept
HQ
San Diego, US
Employees
87↓ 8% decrease
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
View companyGenetic Technologies
HQ
Fitzroy, AU
Employees
55
Genetic Technologies is a molecular diagnostics company that develops and commercializes genetic risk assessment technology.
View companyVeracyte IO
HQ
Marseille, FR
Veracyte IO (also known as HalioDx) is an immuno-oncology diagnostic company providing oncologists with immune-based diagnostic products and services.
View company